NCT03238443View on ClinicalTrials.gov

Interest of the Donor-specific Antibodies After Liver Transplantation

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

February 16, 2016

Primary Completion Date

July 13, 2019

Study Completion Date

July 13, 2019

Conditions
Liver Transplant
Trial Locations (1)

Unknown

CHRU, Hôpital Claude Huriez, Lille

All Listed Sponsors
lead

University Hospital, Lille

OTHER

NCT03238443 - Interest of the Donor-specific Antibodies After Liver Transplantation | Biotech Hunter | Biotech Hunter